Besides vaccines, cell and gene therapies will require extremely intensive cold chains: Jesal Doshi

COVID resulted in a one-time explosion, but the market is fundamentally growing, driven by long-term trends such as the development of RNA, DNA-based treatments, cell and gene therapies, and, in general, the importance of sample storage. Now we will see it being decentralized down to every GP or every pediatrician, and this will require significant investments in the cold chain all around the world. ​

from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/fxJrlYM
https://ift.tt/tDvgOb5

Post a Comment

Previous Post Next Post